| Patents for C07C 213 - Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton (12,264) |
|---|
| 02/24/2000 | DE19837745A1 Optical resolution of primary amines by enantioselective acylation with a long-chain alkoxyalkanoate or phenoxyalkanoate ester in the presence of a lipase |
| 02/24/2000 | CA2339634A1 Amine derivatives |
| 02/24/2000 | CA2339618A1 Stereoselective ring opening reactions |
| 02/23/2000 | CN1245162A Process for preparing amine |
| 02/22/2000 | US6028227 Contacting a mixture of nitrobenzene and water with hydrogen over a solid acid catalyst, solvent extraction, separating the aqueous layer containing the product, concentrating the aqueous layer to obtain the product |
| 02/22/2000 | US6028224 Fluoxetine process from benzoylpropionic acid |
| 02/17/2000 | WO2000007977A1 Novel phenylethylamine derivatives, a method for the production thereof and their use as medicaments |
| 02/17/2000 | WO2000007976A1 Fluoxetine process from benzoylacetonitrile |
| 02/17/2000 | WO2000007709A1 Pesticide formulations containing alkoxylated amine neutralized aromatic sulfonic acid surfactants |
| 02/15/2000 | US6025531 Processes for preparing optically active alcohols and optically active amines |
| 02/15/2000 | US6025517 Fluoxetine process from benzoylacetonitrile |
| 02/10/2000 | WO2000006679A1 Preparation of cationic surfactants containing ester group in molecules |
| 02/10/2000 | WO2000006531A2 Nitric esters and nitrate salts of specific drugs |
| 02/10/2000 | WO2000006527A1 Method for the conversion of 3- and 4-methylcatechol to benzaldehyde |
| 02/10/2000 | WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors |
| 02/10/2000 | DE19829515A1 Metal-modified zeolite catalyst for the hydroxylation of aromatics with nitrous oxide, obtained by treatment of zeolite with gaseous metal salt, e.g. iron-III chloride, followed by calcination at high temperature |
| 02/08/2000 | US6022996 Method for making intermediates useful in synthesis of retroviral protease inhibitors |
| 02/08/2000 | US6022995 Process for the preparation of 2-amino-2-arylethanols and novel intermediates |
| 02/08/2000 | US6022895 Substituted amino compounds and their use as substances having an analgesic effect |
| 02/03/2000 | WO2000005199A1 Improved arylamine synthesis |
| 02/03/2000 | WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors |
| 02/03/2000 | WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 02/03/2000 | DE19834713A1 Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New phenylethylamine derivatives, processes for their preparation and their use as medicaments |
| 02/03/2000 | CA2336976A1 Improved arylamine synthesis |
| 02/02/2000 | EP0975560A1 Chiral separations of amino acids |
| 02/01/2000 | US6020527 Stereospecific isomerisation of allyl amines using chiral phosphorous ligands |
| 01/27/2000 | WO1999063930A3 Novel angiotensin receptor modulators and their uses |
| 01/26/2000 | EP0973755A1 Asymmetric synthesis of benzoxazinones via new intermediates |
| 01/26/2000 | EP0973725A2 New 1,7,7-trimethyl-bicyclo 2.2.1]heptane derivatives |
| 01/26/2000 | EP0973724A1 Novel process for the preparation of (+/-)3- (3,4-dichlorophenyl)-2- dimethylamino-2-methylpropan-1-ol or cericlamine (inn) |
| 01/26/2000 | EP0973723A1 A process for the preparation of an aminoalcohol |
| 01/26/2000 | CN1242358A Process for prepn. of optically pure aminoalcohol |
| 01/25/2000 | US6018069 (2s,3s,5s)-2,5-diamine-1,6-diphenyl-3-hydroxyhexane compounds are purified by obtaining the acid addition salt from a mixture with its (2s,3s,5r) stereoisomer; useful as intermediates to hiv protease inhibitor synthesis |
| 01/25/2000 | CA2146903C Reductive amination catalysts for the selective production of aminoethylethanolamine |
| 01/20/2000 | WO2000002887A2 Ligands for metals and metal-catalyzed processes |
| 01/19/2000 | CN1048498C Enantioselective 1, 3, 2-oxazaborolidine catalysts |
| 01/18/2000 | US6015926 Adding dialkylzinc to chiral additive, adding second additive to form chiral zinc complex, mixing with organometallic reagent, reacting with carbonyl compound to form desired alcohol |
| 01/18/2000 | US6015903 Method of resolving racemic mixtures |
| 01/12/2000 | EP0970935A1 Method of separating optical isomers |
| 01/12/2000 | EP0970066A1 Aminoepoxides from aminoaldehydes and in-situ formed halomethyl organometallic reagent |
| 01/12/2000 | EP0970042A1 5-hydroxymethyl-2-aminotetralins as cardiovascular agents |
| 01/12/2000 | CN1241172A Method of separating optical isomers |
| 01/11/2000 | US6013841 Method for the conversion of 3- and 4-methylcatechol to benzaldehyde |
| 01/11/2000 | US6013801 Method for producing aminoethylethanolamine and/or hydroxyethyl piperazine |
| 01/11/2000 | US6013175 Scavenging mercaptans in a hydrocarbon fluid; preparation of quaternary ammonium hydroxides by reacting tertiary amine and alkylene oxide in presence of water |
| 01/06/2000 | WO2000000459A1 Process for the preparation of optically active trans-cyclohexylamine compounds |
| 01/05/2000 | EP0968174A1 Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock |
| 01/05/2000 | EP0968173A1 Process for the preparation of iodinated contrast agents and intermediates therefor |
| 01/05/2000 | EP0968172A1 Process for preparing n,n,n',n'-tetra-(2-hydroxyethyl)ethylenediamine |
| 01/04/2000 | US6010289 Locking nut, bolt and clip systems and assemblies |
| 12/29/1999 | WO1999067198A1 Desformoterol and process for its preparation |
| 12/29/1999 | WO1999067196A1 Fluoxetine process from benzoylpropionic acid |
| 12/29/1999 | WO1999066944A1 Methods for identifying novel multimeric agents that modulate receptors |
| 12/29/1999 | EP0966423A1 Hydroxymethyl derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene as cardiovascular agent |
| 12/29/1999 | EP0763011B1 Process for the preparation of unsaturated amino compounds |
| 12/29/1999 | CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors |
| 12/28/1999 | US6008413 Process for recrystallizing 1,3-bis(aminophenoxy benzene) |
| 12/28/1999 | US6008412 Reacting n-methyl-3(r,s)-hydroxy-3-phenylpropylamine with s-(+)-mandelic acid; salt formation |
| 12/22/1999 | EP0830337B1 Process for the hydrogenation of imines |
| 12/22/1999 | CN1047590C Hydrogenation process of aromatic nitro derivatives |
| 12/21/1999 | US6005133 Enantioselective oxazaborolidine catalysts |
| 12/21/1999 | US6004913 High di(alkyl fatty ester) quaternary ammonium compound in esteramine from triethanolamine |
| 12/21/1999 | US6004482 Stable aromatic amine composition, and a process for preparing color stable aromatic amines |
| 12/21/1999 | CA2116195C Decolorization of alkanolamines and alkyleneamines |
| 12/21/1999 | CA2079720C Process for monitoring and controlling an alkanolamine reaction process |
| 12/21/1999 | CA1340854C Process for the preparation of 3-substituted derivatives of 1-amino 2-hydroxy-propane |
| 12/16/1999 | WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 12/16/1999 | WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS |
| 12/16/1999 | WO1999064052A1 Novel leukotriene receptor antagonists and their uses |
| 12/16/1999 | WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 12/16/1999 | WO1999064041A1 Multibinding agents that modulate nmda receptors |
| 12/16/1999 | WO1999064038A1 Novel analgesic agents |
| 12/16/1999 | WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS |
| 12/16/1999 | WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS |
| 12/16/1999 | WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS |
| 12/16/1999 | WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors |
| 12/16/1999 | WO1999063999A1 H1-histamine receptor antagonists |
| 12/16/1999 | WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 12/16/1999 | WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors |
| 12/16/1999 | WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS |
| 12/16/1999 | WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors |
| 12/16/1999 | WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors |
| 12/16/1999 | WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 12/16/1999 | WO1999063930A2 Novel angiotensin receptor modulators and their uses |
| 12/16/1999 | DE19826396A1 Verfahren zur Herstellung von Aminen A process for preparing amines |
| 12/16/1999 | CA2321273A1 Novel analgesic agents |
| 12/16/1999 | CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors |
| 12/16/1999 | CA2321152A1 Novel therapeutic agents that modulate endothelin receptors |
| 12/16/1999 | CA2321120A1 .beta.3-adrenergic receptor agonists |
| 12/16/1999 | CA2320926A1 Novel leukotriene receptor antagonists and their uses |
| 12/16/1999 | CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 12/16/1999 | CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 12/16/1999 | CA2319651A1 H1-histamine receptor antagonists |
| 12/16/1999 | CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 12/16/1999 | CA2319497A1 Novel therapeutic agents that modulate estrogen receptors |
| 12/16/1999 | CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 12/16/1999 | CA2319175A1 Multibinding agents that modulate nmda receptors |
| 12/16/1999 | CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors |
| 12/16/1999 | CA2319068A1 Novel angiotensin receptor modulators and their uses |
| 12/16/1999 | CA2318894A1 .beta.2-adrenergic receptor agonists |